$SNTI
Senti Biosciences, Inc.

2022 Q4 Form 10-Q Financial Statement

#000185427022000043 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4
Revenue $59.00K $1.766M $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.91M $10.80M $68.49K
YoY Change 15832.25% 26114.18% -97.71%
% of Gross Profit
Research & Development $9.163M $8.056M $6.410M
YoY Change 42.95% 48.91% 80.06%
% of Gross Profit
Depreciation & Amortization $450.0K $400.0K $230.0K
YoY Change 95.65% 100.0% 76.92%
% of Gross Profit
Operating Expenses $20.08M $18.85M $3.363M
YoY Change 496.93% 6297.98% -48.66%
Operating Profit -$17.09M
YoY Change 49.57%
Interest Expense $1.128M $542.0K $4.860K
YoY Change 23109.88% 18210.81% -112.15%
% of Operating Profit
Other Income/Expense, Net $678.0K $445.0K -$10.00K
YoY Change -6880.0% 2517.65% -100.17%
Pretax Income -$18.21M -$16.64M -$3.358M
YoY Change 442.26% 5604.88% 210.94%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$18.21M -$16.64M -$3.358M
YoY Change 442.26% 5604.88% 210.94%
Net Earnings / Revenue -30864.41% -942.24%
Basic Earnings Per Share -$0.38
Diluted Earnings Per Share -$0.40 -$0.38 -$114.0K
COMMON SHARES
Basic Shares Outstanding 43.86M shares 43.39M shares
Diluted Shares Outstanding 43.42M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.56M $114.9M $889.3K
YoY Change 10982.96% 11574.49%
Cash & Equivalents $57.62M $114.9M $56.03M
Short-Term Investments $40.94M
Other Short-Term Assets $101.0K $56.00K $275.0K
YoY Change -63.27% -91.68%
Inventory
Prepaid Expenses $1.871M $2.277M $798.0K
Receivables $626.0K $846.0K $483.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $102.6M $119.8M $60.19M
YoY Change 70.42% 7125.09%
LONG-TERM ASSETS
Property, Plant & Equipment $56.14M $47.26M $12.37M
YoY Change 353.88% 77.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $293.0K $243.0K $176.0K
YoY Change 66.48% -99.89%
Total Long-Term Assets $78.21M $69.68M $36.51M
YoY Change 114.23% -69.7%
TOTAL ASSETS
Total Short-Term Assets $102.6M $119.8M $60.19M
Total Long-Term Assets $78.21M $69.68M $36.51M
Total Assets $180.8M $189.4M $96.70M
YoY Change 86.96% -18.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.267M $1.768M $5.187M
YoY Change -56.29% 1964344.44%
Accrued Expenses $14.85M $13.84M $3.243M
YoY Change 358.02% 10644.8%
Deferred Revenue $799.0K $99.00K $1.656M
YoY Change -51.75%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.05M $15.84M $14.54M
YoY Change 24.14% 12191.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $35.48M $33.26M $7.050M
YoY Change 403.21% 313.18%
Total Long-Term Liabilities $35.48M $33.26M $7.050M
YoY Change 403.21% 313.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.05M $15.84M $14.54M
Total Long-Term Liabilities $35.48M $33.26M $7.050M
Total Liabilities $53.53M $49.10M $36.33M
YoY Change 47.36% 500.3%
SHAREHOLDERS EQUITY
Retained Earnings -$173.3M -$155.1M -$115.1M
YoY Change 50.55%
Common Stock $4.000K $4.000K $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $127.3M $140.3M -$111.5M
YoY Change
Total Liabilities & Shareholders Equity $180.8M $189.4M $96.70M
YoY Change 86.96% -18.23%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income -$18.21M -$16.64M -$3.358M
YoY Change 442.26% 5604.88% 210.94%
Depreciation, Depletion And Amortization $450.0K $400.0K $230.0K
YoY Change 95.65% 100.0% 76.92%
Cash From Operating Activities -$9.006M -$25.40M -$95.22K
YoY Change 9358.1% 22505.58% -98.63%
INVESTING ACTIVITIES
Capital Expenditures $8.533M $32.84M $3.980M
YoY Change 114.4% 3431.29% 385.37%
Acquisitions
YoY Change
Other Investing Activities -$40.59M $0.00
YoY Change
Cash From Investing Activities -$49.12M -$32.84M $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 876.0K 117.7M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -9.006M -25.40M -95.22K
Cash From Investing Activities -49.12M -32.84M 0.000
Cash From Financing Activities 876.0K 117.7M 0.000
Net Change In Cash -57.25M 59.44M -95.22K
YoY Change 60021.82% -53003.1% -100.43%
FREE CASH FLOW
Cash From Operating Activities -$9.006M -$25.40M -$95.22K
Capital Expenditures $8.533M $32.84M $3.980M
Free Cash Flow -$17.54M -$58.24M -$4.075M
YoY Change 330.38% 5487.22% -47.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001854270
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
P20D
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40440
dei Entity Registrant Name
EntityRegistrantName
Senti Biosciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2437900
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56034000 usd
dei Local Phone Number
LocalPhoneNumber
239-2030
dei Entity Address Address Line1
EntityAddressAddressLine1
2 Corporate Drive, First Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
(650)
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
SNTI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43857077 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114940000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3676000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
119761000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
846000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
483000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3975000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
60193000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3295000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3257000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47259000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12368000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18883000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20708000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
243000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
176000 usd
CY2022Q3 us-gaap Assets
Assets
189441000 usd
CY2021Q4 us-gaap Assets
Assets
96702000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 usd
CY2022Q3 snti Early Exercise Liability Noncurrent
EarlyExerciseLiabilityNoncurrent
179000 usd
CY2021Q4 snti Early Exercise Liability Noncurrent
EarlyExerciseLiabilityNoncurrent
619000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1768000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5187000 usd
CY2022Q3 snti Early Exercise Liability Current
EarlyExerciseLiabilityCurrent
135000 usd
CY2021Q4 snti Early Exercise Liability Current
EarlyExerciseLiabilityCurrent
626000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
99000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1656000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
11913000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
5331000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1922000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1743000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15837000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14543000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32173000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20988000 usd
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
909000 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
176000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
49098000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
36326000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
19517990 shares
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
19517988 shares
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
19517988 shares
CY2022Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0 usd
CY2021Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
163800000 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
27006600 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43638917 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43638917 shares
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
171833000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2972409 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2972409 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
295415000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3619000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-155076000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115076000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
140343000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-111457000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
189441000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96702000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1516000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
926000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3477000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1748000 usd
CY2022Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
250000 usd
CY2021Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
177000 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
750000 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
220000 usd
CY2022Q3 us-gaap Revenues
Revenues
1766000 usd
CY2021Q3 us-gaap Revenues
Revenues
1103000 usd
us-gaap Revenues
Revenues
4227000 usd
us-gaap Revenues
Revenues
1968000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8056000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5410000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24904000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15548000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10795000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7116000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29936000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15981000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
18851000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
12526000 usd
us-gaap Operating Expenses
OperatingExpenses
54840000 usd
us-gaap Operating Expenses
OperatingExpenses
31529000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17085000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11423000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-50613000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-29561000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
542000 usd
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
573000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
7000 usd
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
99000 usd
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8779000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1289000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 snti Fair Value Adjustment Preferred Stock Tranche Liability
FairValueAdjustmentPreferredStockTrancheLiability
0 usd
CY2021Q3 snti Fair Value Adjustment Preferred Stock Tranche Liability
FairValueAdjustmentPreferredStockTrancheLiability
0 usd
snti Fair Value Adjustment Preferred Stock Tranche Liability
FairValueAdjustmentPreferredStockTrancheLiability
0 usd
snti Fair Value Adjustment Preferred Stock Tranche Liability
FairValueAdjustmentPreferredStockTrancheLiability
14742000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
9000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
9000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-110000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
445000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10613000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14854000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-16640000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16640000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-11406000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11406000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-40000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-44415000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44415000 usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.90
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-15.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15.33
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43424172 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43424172 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2925957 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2925957 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20150459 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20150459 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2897850 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2897850 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11536136 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
89662000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-58713000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
6000 usd
CY2021Q1 snti Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
277977 shares
CY2021Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
2294000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1432000 usd
CY2021Q1 snti Early Exercise Of Stock Options Value
EarlyExerciseOfStockOptionsValue
1329000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
372000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-21002000 usd
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11814113 shares
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
91956000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-79240000 usd
CY2021Q2 snti Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
7703875 shares
CY2021Q2 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
79877000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000 usd
CY2021Q2 snti Stock Issued During Period Value Vesting Of Early Exercise Of Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExerciseOfStockOptions
28000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
562000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-12007000 usd
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
19517988 shares
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
171833000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-90636000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 usd
CY2021Q3 snti Stock Issued During Period Value Vesting Of Early Exercise Of Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExerciseOfStockOptions
28000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
626000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-11406000 usd
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
19517988 shares
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
171833000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-101369000 usd
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
19517988 shares
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
171833000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-111457000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
422000 usd
CY2022Q1 snti Stock Issued During Period Value Vesting Of Early Exercise Of Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExerciseOfStockOptions
375000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
661000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-11808000 usd
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
19517988 shares
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
171833000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-121807000 usd
CY2022Q2 snti Temporary Equity Shares Conversion Of Convertible Securities
TemporaryEquitySharesConversionOfConvertibleSecurities
19517988 shares
CY2022Q2 snti Temporary Equity Value Conversion Of Convertible Securities
TemporaryEquityValueConversionOfConvertibleSecurities
171833000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
171835000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
112182000 usd
CY2022Q2 snti Adjustments To Additional Paid In Capital Contingent Consideration Liability On Closing Of The Reverse Recapitalization
AdjustmentsToAdditionalPaidInCapitalContingentConsiderationLiabilityOnClosingOfTheReverseRecapitalization
9688000 usd
CY2022Q2 snti Stock Issued During Period Value Cancellation And Exchange Of Convertible Debt
StockIssuedDuringPeriodValueCancellationAndExchangeOfConvertibleDebt
5184000 usd
CY2022Q2 snti Adjustments To Additional Paid In Capital Gain On Embedded Derivative
AdjustmentsToAdditionalPaidInCapitalGainOnEmbeddedDerivative
-1289000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
74000 usd
CY2022Q2 snti Stock Issued During Period Value Vesting Of Early Exercise Of Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExerciseOfStockOptions
102000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9225000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11552000 usd
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
154266000 usd
CY2022Q3 snti Stock Issued During Period Value Purchase Agreement Fee Settled In Stock
StockIssuedDuringPeriodValuePurchaseAgreementFeeSettledInStock
196000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
223000 usd
CY2022Q3 snti Stock Issued During Period Value Vesting Of Early Exercise Of Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExerciseOfStockOptions
454000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2290000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-16640000 usd
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
140343000 usd
us-gaap Net Income Loss
NetIncomeLoss
-40000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-44415000 usd
us-gaap Depreciation
Depreciation
948000 usd
us-gaap Depreciation
Depreciation
543000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2028000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1433000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1289000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8779000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
snti Fair Value Adjustment Preferred Stock Tranche Liability
FairValueAdjustmentPreferredStockTrancheLiability
0 usd
snti Fair Value Adjustment Preferred Stock Tranche Liability
FairValueAdjustmentPreferredStockTrancheLiability
14742000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
12176000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1560000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-13000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9000 usd
snti Stock Issued For Purchase Agreement Fee
StockIssuedForPurchaseAgreementFee
196000 usd
snti Stock Issued For Purchase Agreement Fee
StockIssuedForPurchaseAgreementFee
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
8000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
363000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
345000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1837000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1581000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
93000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1716000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1488000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2416000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1733000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2232000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
11161000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-974000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25890000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22664000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32841000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1558000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32841000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1558000 usd
snti Proceeds From Merger And Related Pipe Financing Net Of Transaction Costs
ProceedsFromMergerAndRelatedPIPEFinancingNetOfTransactionCosts
111979000 usd
snti Proceeds From Merger And Related Pipe Financing Net Of Transaction Costs
ProceedsFromMergerAndRelatedPIPEFinancingNetOfTransactionCosts
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
521000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1460000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5175000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
66952000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
117675000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68412000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
58944000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44190000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59291000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31034000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118235000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75224000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114940000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73692000 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
3295000 usd
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
1532000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118235000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75224000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7360000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1092000 usd
snti Recognition Of Preferred Stock Tranche Liability
RecognitionOfPreferredStockTrancheLiability
0 usd
snti Recognition Of Preferred Stock Tranche Liability
RecognitionOfPreferredStockTrancheLiability
33000 usd
snti Extinguishment Of Preferred Stock Tranche Liability
ExtinguishmentOfPreferredStockTrancheLiability
0 usd
snti Extinguishment Of Preferred Stock Tranche Liability
ExtinguishmentOfPreferredStockTrancheLiability
15210000 usd
snti Deferred Transaction Costs Related To Pending Business Combination In Accounts Payable And Accrued Expenses
DeferredTransactionCostsRelatedToPendingBusinessCombinationInAccountsPayableAndAccruedExpenses
0 usd
snti Deferred Transaction Costs Related To Pending Business Combination In Accounts Payable And Accrued Expenses
DeferredTransactionCostsRelatedToPendingBusinessCombinationInAccountsPayableAndAccruedExpenses
140000 usd
snti Receivables In Transit From Issuance Of Common Stock Upon Exercise Of Stock Options
ReceivablesInTransitFromIssuanceOfCommonStockUponExerciseOfStockOptions
0 usd
snti Receivables In Transit From Issuance Of Common Stock Upon Exercise Of Stock Options
ReceivablesInTransitFromIssuanceOfCommonStockUponExerciseOfStockOptions
12000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-155100000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115100000 usd
us-gaap Net Income Loss
NetIncomeLoss
-40000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-44400000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118200000 usd
snti Number Of Business Activities
NumberOfBusinessActivities
1 businessactivitiy
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 reportablesegment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the valuation of stock-based awards, the accrual for research and development expenses, the valuation of contingent earnout, the valuation of convertible notes, the valuation of common and redeemable convertible preferred stock, the valuation of preferred stock tranche liability, standalone selling price (“SSP”) and the determination of the incremental borrowing rate. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></div>
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Shares
ReverseRecapitalizationContingentConsiderationEquityShares
2000000 shares
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Number Of Tranches
ReverseRecapitalizationContingentConsiderationEquityNumberOfTranches
2 tranche
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Shares Per Tranche
ReverseRecapitalizationContingentConsiderationEquitySharesPerTranche
1000000 shares
CY2022Q2 snti Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.1957
CY2022Q2 snti Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.1957
CY2022Q2 snti Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.1957
CY2022Q2 snti Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.1957
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Shares
ReverseRecapitalizationContingentConsiderationEquityShares
2000000 shares
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Number Of Tranches
ReverseRecapitalizationContingentConsiderationEquityNumberOfTranches
2 tranche
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Shares Per Tranche
ReverseRecapitalizationContingentConsiderationEquitySharesPerTranche
1000000 shares
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
P20D
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Consecutive Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays
P30D
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Threshold Of Years For Change Of Control
ReverseRecapitalizationContingentConsiderationEquityThresholdOfYearsForChangeOfControl
P3Y
CY2022Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5060000 shares
CY2022Q2 snti Stock Converted Reverse Recapitalization
StockConvertedReverseRecapitalization
23163614 shares
CY2022Q2 snti Early Exercised Shares Subject To Repurchase
EarlyExercisedSharesSubjectToRepurchase
288807 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43368270 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
19517988 shares
CY2022Q2 snti Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
140700000 usd
CY2022Q2 snti Reverse Recapitalization Transaction Costs
ReverseRecapitalizationTransactionCosts
23500000 usd
CY2022Q2 snti Reverse Recapitalization Transaction Costs Incurred By Company
ReverseRecapitalizationTransactionCostsIncurredByCompany
4800000 usd
snti Reverse Recapitalization Accrued Transaction Costs
ReverseRecapitalizationAccruedTransactionCosts
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118235000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118235000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59291000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59291000 usd
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
118235000 usd
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
909000 usd
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
909000 usd
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
59291000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2277000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
798000 usd
CY2022Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1642000 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1157000 usd
CY2022Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1446000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
56000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
275000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3975000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
20000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3676000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49811000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14023000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2552000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1655000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47259000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12368000 usd
us-gaap Depreciation
Depreciation
900000 usd
us-gaap Depreciation
Depreciation
500000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
400000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
200000 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6828000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
605000 usd
CY2022Q3 snti Accrued Professional Fees Other Current
AccruedProfessionalFeesOtherCurrent
2465000 usd
CY2021Q4 snti Accrued Professional Fees Other Current
AccruedProfessionalFeesOtherCurrent
1950000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2566000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2665000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
54000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
111000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
11913000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
5331000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1326000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1110000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3976000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2469000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.091
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.091
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
184000 usd
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
50000 usd
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
160000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
537000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
564000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
1530000 usd
CY2021Q3 us-gaap Lease Cost
LeaseCost
1270000 usd
us-gaap Lease Cost
LeaseCost
4563000 usd
us-gaap Lease Cost
LeaseCost
3033000 usd
snti Operating Lease Proceeds Payments
OperatingLeaseProceedsPayments
9225000 usd
snti Operating Lease Proceeds Payments
OperatingLeaseProceedsPayments
-1995000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
202000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9825000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y2M12D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M24D
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
697000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6272000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7265000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7489000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7723000 usd
CY2022Q3 snti Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
30229000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
59675000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19402000 usd
CY2022Q3 snti Tenant Improvement Allowance Remaining Amount
TenantImprovementAllowanceRemainingAmount
6178000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
34095000 usd
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
19517990 shares
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
19517988 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
19517988 shares
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
171833000 usd
CY2021Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
163834000 usd
CY2022Q2 snti Temporary Equity Conversion Ratio
TemporaryEquityConversionRatio
1
CY2022Q3 snti Number Of Votes Per Common Share
NumberOfVotesPerCommonShare
1 vote
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
27006600 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
22609888 shares
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
23000816 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Shares
ReverseRecapitalizationContingentConsiderationEquityShares
2000000 shares
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Number Of Tranches
ReverseRecapitalizationContingentConsiderationEquityNumberOfTranches
2 tranche
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Shares Per Tranche
ReverseRecapitalizationContingentConsiderationEquitySharesPerTranche
1000000 shares
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Consecutive Trading Days
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays
P30D
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Threshold Of Years For Change Of Control
ReverseRecapitalizationContingentConsiderationEquityThresholdOfYearsForChangeOfControl
P3Y
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Fair Value
ReverseRecapitalizationContingentConsiderationFairValue
9800000 usd
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9700000 usd
CY2022Q2 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
100000 usd
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
100000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8800000 usd
CY2019Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
300000 usd
CY2019Q2 snti Revenue Remaining Performance Obligation Variable Consideration Amount
RevenueRemainingPerformanceObligationVariableConsiderationAmount
300000 usd
CY2021Q4 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract
-300000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
700000 usd
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1700000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
800000 usd
CY2022Q3 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0 usd
CY2021Q3 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2291838 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.39
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11304000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1510059 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.83
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
199807 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
529221 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.16
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3072869 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
527000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
583348 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
29000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2290000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
626000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12176000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1560000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
23900000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M4D
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
9200000 usd
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-16640000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-11406000 usd
us-gaap Net Income Loss
NetIncomeLoss
-40000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-44415000 usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43424172 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43424172 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2925957 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2925957 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20150459 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20150459 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2897850 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2897850 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.90
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Shares
ReverseRecapitalizationContingentConsiderationEquityShares
2000000 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-15.33
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10875278 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10875278 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21832990 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21832990 shares
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
46000000 usd
CY2021Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
snti Collaborative Arrangement Rights And Obligations Contractual Annual Payments
CollaborativeArrangementRightsAndObligationsContractualAnnualPayments
100000 usd
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Number Of Tranches
ReverseRecapitalizationContingentConsiderationEquityNumberOfTranches
2 tranche
CY2022Q2 snti Reverse Recapitalization Contingent Consideration Equity Shares Per Tranche
ReverseRecapitalizationContingentConsiderationEquitySharesPerTranche
1000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 snti Number Of Seats On The Board Of Directors
NumberOfSeatsOnTheBoardOfDirectors
7 tradingday
CY2021Q4 snti Number Of Seats On The Board Of Directors
NumberOfSeatsOnTheBoardOfDirectors
7 tradingday
CY2021Q4 snti Number Of Seats On The Board Of Directors
NumberOfSeatsOnTheBoardOfDirectors
7 tradingday

Files In Submission

Name View Source Status
0001854270-22-000043-index-headers.html Edgar Link pending
0001854270-22-000043-index.html Edgar Link pending
0001854270-22-000043.txt Edgar Link pending
0001854270-22-000043-xbrl.zip Edgar Link pending
a9302210qex101.htm Edgar Link pending
a9302210qex102.htm Edgar Link pending
a9302210qex103.htm Edgar Link pending
a9302210qex104.htm Edgar Link pending
a9302210qex105.htm Edgar Link pending
a9302210qex106.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
senti09302210qex311.htm Edgar Link pending
senti09302210qex312.htm Edgar Link pending
senti09302210qex321.htm Edgar Link pending
senti09302210qex322.htm Edgar Link pending
Show.js Edgar Link pending
snti-20220930.htm Edgar Link pending
snti-20220930.xsd Edgar Link pending
snti-20220930_lab.xml Edgar Link unprocessable
snti-20220930_pre.xml Edgar Link unprocessable
snti-20220930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
snti-20220930_def.xml Edgar Link unprocessable
snti-20220930_cal.xml Edgar Link unprocessable